SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-18-004474
Filing Date
2018-10-24
Accepted
2018-10-24 16:25:26
Documents
1
Period of Report
2018-10-17

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 3510
  Complete submission text file 0001567619-18-004474.txt   4846
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD SUITE 400 ROCKVILLE MD 20853
Business Address
Havey Adam (Reporting) CIK: 0001514588 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33137 | Film No.: 181136691